Brokerages expect Forty Seven Inc (NASDAQ:FTSV) to post earnings per share of ($0.69) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Forty Seven’s earnings. The highest EPS estimate is ($0.55) and the lowest is ($0.76). Forty Seven posted earnings per share of ($2.52) during the same quarter last year, which indicates a positive year-over-year growth rate of 72.6%. The company is scheduled to report its next earnings report on Monday, August 12th.
On average, analysts expect that Forty Seven will report full-year earnings of ($2.72) per share for the current financial year, with EPS estimates ranging from ($3.03) to ($2.32). For the next fiscal year, analysts anticipate that the business will report earnings of ($2.62) per share, with EPS estimates ranging from ($3.03) to ($2.23). Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that that provide coverage for Forty Seven.
Forty Seven (NASDAQ:FTSV) last posted its earnings results on Monday, May 13th. The company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.14).
In related news, insider Mark Anthony Mccamish sold 16,500 shares of the stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $12.10, for a total transaction of $199,650.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Chris H. Takimoto sold 8,000 shares of the stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $16.39, for a total value of $131,120.00. The disclosure for this sale can be found here. Insiders have sold 169,811 shares of company stock worth $2,921,746 in the last three months. 37.40% of the stock is currently owned by company insiders.
Large investors have recently modified their holdings of the stock. BlackRock Inc. lifted its stake in Forty Seven by 34.7% during the first quarter. BlackRock Inc. now owns 1,139,596 shares of the company’s stock worth $18,416,000 after purchasing an additional 293,642 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Forty Seven by 51.2% during the third quarter. JPMorgan Chase & Co. now owns 346,066 shares of the company’s stock worth $5,164,000 after purchasing an additional 117,142 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in Forty Seven by 42.8% during the first quarter. Goldman Sachs Group Inc. now owns 178,359 shares of the company’s stock worth $2,882,000 after purchasing an additional 53,498 shares during the last quarter. Vanguard Group Inc lifted its stake in Forty Seven by 144.4% during the third quarter. Vanguard Group Inc now owns 171,060 shares of the company’s stock worth $2,553,000 after purchasing an additional 101,060 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Forty Seven by 144.4% during the third quarter. Vanguard Group Inc. now owns 171,060 shares of the company’s stock worth $2,553,000 after purchasing an additional 101,060 shares during the last quarter. 47.34% of the stock is currently owned by institutional investors and hedge funds.
Forty Seven stock opened at $10.95 on Tuesday. Forty Seven has a 12 month low of $10.50 and a 12 month high of $23.83. The company has a market capitalization of $358.12 million and a PE ratio of -2.92.
About Forty Seven
Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody.
Recommended Story: How Do You Make Money With Penny Stocks?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Forty Seven Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forty Seven and related companies with MarketBeat.com's FREE daily email newsletter.